Skip to content
Screener

Relay Therapeutics, Inc. RLAY Total Current Assets

Total Current Assets at other companies

Schrodinger logo
SchrodingerSDGR
$470.48M-8.5%
PVL
Palvella TherapeuticsPVLA
$263.23M+231%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$603.46M+2.8%
Celcuity logo
CelcuityCELC
$408.93M+87.9%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$4.03B+85.1%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$1.46B+313%

Other financials

Income statement

See full
Revenue$350.0K-48.3%
Operating income-$90.8M-18.2%
Net income-$83.7M-18.9%
EPS (diluted)-$0.410.0%

Balance sheet

See full
Cash & equivalents$121.2M+6.4%
Total debt$30.7M-10.3%
Total equity$890.0M+33.7%
Total assets$967.5M+32.7%

Cash flow

See full
Operating cash flow-$54.1M+2.1%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$4.3B+611%
Enterprise value$4.21B+702%
P/S415.9×+343×

Profitability

See full
Operating margin-2,999.4%-637pp
Net margin-2,763.6%-568pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-36.8%-6.3pp
Debt / equity0.0×
Current ratio18.3×-2.7×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338056
Line itemJune 30, 2026December 31, 2025
Investments789,745470,500
Prepaid expenses8,73517,787
Other current assets8,4135,974
Total current assets928,082578,279
Property and equipment, net8621,726
Operating lease assets37,17739,990
Restricted cash1,3361,336
Total assets$967,457$621,331

Item 1. Financial Statements.

FAQ

What is Relay Therapeutics, Inc.'s total current assets?
Relay Therapeutics, Inc. (RLAY) reported total current assets of $928.08M in Q2 2026.
How has Relay Therapeutics, Inc.'s total current assets changed year-over-year?
Relay Therapeutics, Inc.'s total current assets increased by 36.4% year-over-year, from $680.39M to $928.08M.
What is the long-term trend for Relay Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total current assets has grown at a -5.6% compound annual growth rate (CAGR), from $770.1M to $578.28M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Relay Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude